Six years after COVID-19 first made headlines, an antiviral pill has finally been shown to stop users from developing the disease after being exposed to...
U.S. health officials have stopped the publication of a study on whether the COVID-19 vaccine was keeping adults from becoming sick enough to have to...
A recently released study suggests that fluvoxamine, a low‑cost and widely available antidepressant, “significantly improved fatigue and quality of life among adults with long COVID.”...